Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
117
NMPA:117
Drug Approvals
Terbutaline Sulfate Oral Solution
- Product Name
- 硫酸特布他林口服溶液
- Approval Number
- 国药准字H20249477
- Approval Date
- Dec 1, 2024
NMPA
Terbutaline Sulfate Oral Solution
- Product Name
- 硫酸特布他林口服溶液
- Approval Number
- 国药准字H20249476
- Approval Date
- Dec 1, 2024
NMPA
Polyethylene Glycol Electrolytes Powder（Ⅲ）
- Product Name
- 复方聚乙二醇电解质散(Ⅲ)
- Approval Number
- 国药准字H20249080
- Approval Date
- Oct 16, 2024
NMPA
Terbutaline Sulfate Injection
- Product Name
- 硫酸特布他林注射液
- Approval Number
- 国药准字H20243144
- Approval Date
- Feb 6, 2024
NMPA
Tranexamic Acid Injection
- Product Name
- 氨甲环酸注射液
- Approval Number
- 国药准字H20093557
- Approval Date
- Feb 6, 2024
NMPA
Tranexamic Acid Injection
- Product Name
- 氨甲环酸注射液
- Approval Number
- 国药准字H20093558
- Approval Date
- Feb 6, 2024
NMPA
Tranexamic Acid Injection
- Product Name
- 氨甲环酸注射液
- Approval Number
- 国药准字H20227069
- Approval Date
- Nov 30, 2023
NMPA
Urapidil Hydrochloride Injection
- Product Name
- 盐酸乌拉地尔注射液
- Approval Number
- 国药准字H20234352
- Approval Date
- Oct 24, 2023
NMPA
Urapidil Hydrochloride Injection
- Product Name
- 盐酸乌拉地尔注射液
- Approval Number
- 国药准字H20234351
- Approval Date
- Oct 24, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 12
- Next
Clinical Trials
No trials found
News
No news found